Functional recovery after cervical spinal cord injury: Role of neurotrophin and glutamatergic signaling in phrenic motoneurons.
Cervical spinal cord injury (SCI) interrupts descending neural drive to phrenic motoneurons causing diaphragm muscle (DIAm) paralysis. Recent studies using a well-established model of SCI, unilateral spinal hemisection of the C2 segment of the cervical spinal cord (SH), provide novel information regarding the molecular and cellular mechanisms of functional recovery after SCI. Over time post-SH, gradual recovery of rhythmic ipsilateral DIAm activity occurs. Recovery of ipsilateral DIAm electromyogram (EMG) activity following SH is enhanced by increasing brain-derived neurotrophic factor (BDNF) in the region of the phrenic motoneuron pool. Delivery of exogenous BDNF either via intrathecal infusion or via mesenchymal stem cells engineered to release BDNF similarly enhance recovery. Conversely, recovery after SH is blunted by quenching endogenous BDNF with the fusion-protein TrkB-Fc in the region of the phrenic motoneuron pool or by selective inhibition of TrkB kinase activity using a chemical-genetic approach in TrkB(F616A) mice. Furthermore, the importance of BDNF signaling via TrkB receptors at phrenic motoneurons is highlighted by the blunting of recovery by siRNA-mediated downregulation of TrkB receptor expression in phrenic motoneurons and by the enhancement of recovery evident following virally-induced increases in TrkB expression specifically in phrenic motoneurons. BDNF/TrkB signaling regulates synaptic plasticity in various neuronal systems, including glutamatergic pathways. Glutamatergic neurotransmission constitutes the main inspiratory-related, excitatory drive to motoneurons, and following SH, spontaneous neuroplasticity is associated with increased expression of ionotropic N-methyl-d-aspartate (NMDA) receptors in phrenic motoneurons. Evidence for the role of BDNF/TrkB and glutamatergic signaling in recovery of DIAm activity following cervical SCI is reviewed.
Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55906, United States.
Luther C
LC
Gill
Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55906, United States.
Heather M
HM
Gransee
Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55906, United States; Department of Anesthesiology, Mayo Clinic, Rochester, MN 55906, United States.
Gary C
GC
Sieck
Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55906, United States; Department of Anesthesiology, Mayo Clinic, Rochester, MN 55906, United States. Electronic address: mantilla.carlos@mayo.edu.
Carlos B
CB
Mantilla
D000818:Animals; D066193:Cervical Cord / Q000293:injuries* / Q000378:metabolism*; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D009046:Motor Neurons / Q000378:metabolism; D009414:Nerve Growth Factors / Q000378:metabolism; D010791:Phrenic Nerve / Q000378:metabolism; D020127:Recovery of Function / Q000502:physiology*; D012119:Respiration; D015398:Signal Transduction; D013119:Spinal Cord Injuries / Q000378:metabolism*
D009414:Nerve Growth Factors; D018698:Glutamic Acid
Brain-derived neurotrophic factor; Diaphragm muscle; Phrenic motoneuron; Respiration; Trk receptor